Annual SGA
$10.37 M
-$727.00 K-6.55%
December 31, 2023
Summary
- As of March 12, 2025, MTNB annual SGA is $10.37 million, with the most recent change of -$727.00 thousand (-6.55%) on December 31, 2023.
- During the last 3 years, MTNB annual SGA has risen by +$367.00 thousand (+3.67%).
- MTNB annual SGA is now -6.55% below its all-time high of $11.10 million, reached on December 31, 2022.
Performance
MTNB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.14 M
-$326.00 K-13.21%
September 30, 2024
Summary
- As of March 12, 2025, MTNB quarterly SGA is $2.14 million, with the most recent change of -$326.00 thousand (-13.21%) on September 30, 2024.
- Over the past year, MTNB quarterly SGA has dropped by -$697.00 thousand (-24.55%).
- MTNB quarterly SGA is now -31.89% below its all-time high of $3.15 million, reached on March 31, 2021.
Performance
MTNB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$735.48 M
-$21.13 M-2.96%
September 30, 2024
Summary
- As of March 12, 2025, MTNB TTM SGA is -$735.48 million, with the most recent change of -$21.13 million (-2.96%) on September 30, 2024.
- Over the past year, MTNB TTM SGA has dropped by -$746.30 million (-6892.99%).
- MTNB TTM SGA is now -19099.55% below its all-time high of -$3.83 million.
Performance
MTNB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MTNB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -24.6% | -6893.0% |
| 3 y3 years | +3.7% | -24.6% | -6893.0% |
| 5 y5 years | +30.0% | -24.6% | -6893.0% |
MTNB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +1.9% | -25.1% | at low | -51.0% | at low |
| 5 y | 5-year | -6.5% | +33.4% | -31.9% | at low | -139.6% | at low |
| alltime | all time | -6.5% | +431.7% | -31.9% | +3327.2% | <-9999.0% | at low |
Matinas BioPharma Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.14 M(-13.2%) | $9.29 M(-7.0%) |
| Jun 2024 | - | $2.47 M(+0.5%) | $9.98 M(-1.3%) |
| Mar 2024 | - | $2.46 M(+10.5%) | $10.12 M(-2.5%) |
| Dec 2023 | $10.37 M(-6.5%) | $2.22 M(-21.7%) | $10.37 M(-4.2%) |
| Sep 2023 | - | $2.84 M(+9.2%) | $10.83 M(+0.2%) |
| Jun 2023 | - | $2.60 M(-4.1%) | $10.81 M(-2.4%) |
| Mar 2023 | - | $2.71 M(+1.3%) | $11.07 M(-0.3%) |
| Dec 2022 | $11.10 M(+9.0%) | $2.68 M(-5.0%) | $11.10 M(+1.8%) |
| Sep 2022 | - | $2.82 M(-1.5%) | $10.90 M(+5.4%) |
| Jun 2022 | - | $2.86 M(+4.3%) | $10.34 M(+5.6%) |
| Mar 2022 | - | $2.74 M(+10.9%) | $9.78 M(-3.9%) |
| Dec 2021 | $10.19 M(+1.8%) | $2.47 M(+9.6%) | $10.19 M(-5.1%) |
| Sep 2021 | - | $2.26 M(-2.3%) | $10.74 M(-1.0%) |
| Jun 2021 | - | $2.31 M(-26.6%) | $10.84 M(-0.4%) |
| Mar 2021 | - | $3.15 M(+3.9%) | $10.89 M(+8.8%) |
| Dec 2020 | $10.01 M(+28.7%) | $3.03 M(+28.0%) | $10.01 M(+7.6%) |
| Sep 2020 | - | $2.36 M(+0.3%) | $9.30 M(+5.4%) |
| Jun 2020 | - | $2.36 M(+4.3%) | $8.82 M(+7.0%) |
| Mar 2020 | - | $2.26 M(-2.4%) | $8.25 M(+6.1%) |
| Dec 2019 | $7.78 M(-2.5%) | $2.32 M(+22.6%) | $7.78 M(-2.0%) |
| Sep 2019 | - | $1.89 M(+6.1%) | $7.93 M(+4.1%) |
| Jun 2019 | - | $1.78 M(-0.4%) | $7.62 M(-2.4%) |
| Mar 2019 | - | $1.79 M(-27.7%) | $7.81 M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $7.98 M(+4.4%) | $2.47 M(+57.1%) | $7.98 M(+1.2%) |
| Sep 2018 | - | $1.57 M(-20.1%) | $7.88 M(+1.7%) |
| Jun 2018 | - | $1.97 M(+0.7%) | $7.75 M(+3.5%) |
| Mar 2018 | - | $1.96 M(-17.6%) | $7.48 M(-2.1%) |
| Dec 2017 | $7.64 M(+77.3%) | $2.38 M(+65.1%) | $7.64 M(+21.7%) |
| Sep 2017 | - | $1.44 M(-15.6%) | $6.28 M(+7.5%) |
| Jun 2017 | - | $1.71 M(-19.4%) | $5.84 M(+14.3%) |
| Mar 2017 | - | $2.12 M(+108.4%) | $5.11 M(+18.6%) |
| Dec 2016 | $4.31 M(-10.5%) | $1.02 M(+1.7%) | $4.31 M(-3.5%) |
| Sep 2016 | - | $999.80 K(+2.3%) | $4.47 M(-7.1%) |
| Jun 2016 | - | $977.70 K(-25.7%) | $4.81 M(-3.0%) |
| Mar 2016 | - | $1.32 M(+12.2%) | $4.95 M(+2.9%) |
| Dec 2015 | $4.81 M(-9.0%) | $1.17 M(-12.5%) | $4.81 M(-4.4%) |
| Sep 2015 | - | $1.34 M(+19.2%) | $5.04 M(-3.7%) |
| Jun 2015 | - | $1.12 M(-4.6%) | $5.23 M(-3.3%) |
| Mar 2015 | - | $1.18 M(-15.7%) | $5.41 M(+2.3%) |
| Dec 2014 | $5.29 M(+171.1%) | $1.40 M(-9.1%) | $5.29 M(+6.4%) |
| Sep 2014 | - | $1.54 M(+17.9%) | $4.97 M(+20.0%) |
| Jun 2014 | - | $1.30 M(+23.4%) | $4.14 M(+40.7%) |
| Mar 2014 | - | $1.06 M(-2.0%) | $2.94 M(+50.9%) |
| Dec 2013 | $1.95 M | $1.08 M(+52.1%) | $1.95 M(+123.3%) |
| Sep 2013 | - | $708.10 K(+585.5%) | $873.90 K(+427.1%) |
| Jun 2013 | - | $103.30 K(+65.3%) | $165.80 K(+165.3%) |
| Mar 2013 | - | $62.50 K | $62.50 K |
FAQ
- What is Matinas BioPharma Holdings annual SGA?
- What is the all time high annual SGA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual SGA year-on-year change?
- What is Matinas BioPharma Holdings quarterly SGA?
- What is the all time high quarterly SGA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly SGA year-on-year change?
- What is Matinas BioPharma Holdings TTM SGA?
- What is the all time high TTM SGA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM SGA year-on-year change?
What is Matinas BioPharma Holdings annual SGA?
The current annual SGA of MTNB is $10.37 M
What is the all time high annual SGA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual SGA is $11.10 M
What is Matinas BioPharma Holdings annual SGA year-on-year change?
Over the past year, MTNB annual SGA has changed by -$727.00 K (-6.55%)
What is Matinas BioPharma Holdings quarterly SGA?
The current quarterly SGA of MTNB is $2.14 M
What is the all time high quarterly SGA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly SGA is $3.15 M
What is Matinas BioPharma Holdings quarterly SGA year-on-year change?
Over the past year, MTNB quarterly SGA has changed by -$697.00 K (-24.55%)
What is Matinas BioPharma Holdings TTM SGA?
The current TTM SGA of MTNB is -$735.48 M
What is the all time high TTM SGA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM SGA is -$3.83 M
What is Matinas BioPharma Holdings TTM SGA year-on-year change?
Over the past year, MTNB TTM SGA has changed by -$746.30 M (-6892.99%)